October, 2022

article thumbnail

Interview with the Jones!Lab on development of novel genome editing tools

Drug Discovery Today

On October 26?27, Vilnius will host the EFIB’2022 event which will bring the European life science sector together. In the field of life sciences, Lithuania is best known for the discovery of gene scissors by Prof. Virginijus Šikšnys. The country now hosts the EMBL Partnership Institute for Genome Editing Technologies at the Vilnius University Life Sciences Center aiming to advance gene editing technologies.

Science 214
article thumbnail

#Unshackled: The evolving definition of asset-centricity

DrugBaron

Asset-centric is a term coined by Medicxi founding partner Francesco De Rubertis to describe an investment strategy he pioneered, together with Kevin Johnson and Michele Ollier, in the early years of the 21 st Century. The key was focusing investment on a single asset to avoid the problem with pipelines in early-stage biotech companies. While it seemed superficially attractive to hedge against failure of the lead asset by having a second or a third program in the wings, the reality usually turne

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

How do I become a medical studies participant?

Antidote

Throughout history, clinical trials have been an important element in learning about new drugs and treatments — but without patient participation, the medical remedies that are so ubiquitous in our lives today would not exist. Because it’s required for all drugs to go through testing before they are released on the market, volunteers for clinical trials have a major impact on medical research as a whole.

article thumbnail

6 Operational Considerations You Need To Know for Psychedelic Trials

Conversations in Drug Development Trends

Bringing a psychedelic into a clinical trial setting is complex and requires a thorough operational approach to ensure the study’s success. Having worked in psychedelic research since the advent of industry-sponsored trials, Worldwide Clinical Trials has amassed the expertise needed to execute these studies successfully, recently sharing insights in a webinar titled “ Demystifying Complex Operations in Psychedelic Research ,” available on-demand now.

Trials 97
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Mapping the Vertical Integration of Insurers, PBMs, Specialty Pharmacies, and Providers: A 2022 Update

Drug Channels

I conservatively estimate that I’ve created about 1,374,613 slides during my career. But there are two slides that people seem to appreciate the most. One is my chart showing the key channel flows within the entire U.S. pharmaceutical distribution, payment, and reimbursement system. The other is my mapping of the insurer/PBM/specialty pharmacy/provider organizations that now dominate U.S. drug channels.

article thumbnail

Tick Tock re Tik Tok and FDA’s OPDP

Eye on FDA

Tik Tok was first released in 2016. While slow out of the starting gate with emergent media opportunities, in 2022, pharma is embracing the platform in both unbranded and branded efforts. While historically, a lot of Tik Tok use has been comprised of individuals releasing videos of them showing off dance moves and physique, the time for embracing the platform by institutional users appears has arrived.

FDA 89

More Trending

article thumbnail

New patent for Insmed Inc drug ARIKAYCE KIT

Drug Patent Watch

Annual Drug Patent Expirations for ARIKAYCE+KIT Arikayce Kit is a drug marketed by Insmed Inc and is included in one NDA. There are eleven patents protecting this drug. This drug…. The post New patent for Insmed Inc drug ARIKAYCE KIT appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 88
article thumbnail

How to participate in a research study

Antidote

Different types of clinical studies are designed to investigate potential therapies, medications, and medical devices — and all of these must go through each phase of a clinical trial before they are approved. This means that volunteers who are willing to participate in research studies are essential to medical breakthroughs and the advancement of knowledge surrounding any given condition.

article thumbnail

IND Data Requirements and US FDA Submission Process

ProRelix Research

A clinical trial is a culmination of the several stages of a drug or medical device development program that begins with the discovery of a candidate molecule followed by preclinical […]. The post IND Data Requirements and US FDA Submission Process appeared first on ProRelix Research.

FDA 52
article thumbnail

vitaCare From GoodRx Reimagines Prescription Services for a Wider Range of Patients and Treatments Than Traditional Hub Services (Guest Post)

Drug Channels

Today’s guest post comes from Jon Lanznar, Chief Strategy Officer at vitaCare Prescription Services from GoodRx. Jon discusses vitaCare , a pharmacy services platform acquired by GoodRx earlier this year. vitaCare helps patients understand coverage, identifies available savings opportunities, and facilitates communications between providers and payers.

article thumbnail

How Machine Learning Drives Clinical Trial Efficiency

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

article thumbnail

Leveraging PDX Models for Modeling Metastatic Breast Cancer

Crown Bioscience

Major advances in breast cancer treatment have significantly improved survival rates, but metastatic disease continues to be the leading cause of breast cancer-related deaths. Developing novel therapies for metastatic breast cancer requires preclinical breast cancer models that better-recapitulate important clinical features of the disease, including metastasis.

article thumbnail

Interview with the Jones!Lav on development of novel genome editing tools

Drug Discovery Today

On October 26?27, Vilnius will host the EFIB’2022 event which will bring the European life science sector together. In the field of life sciences, Lithuania is best known for the discovery of gene scissors by Prof. Virginijus Šikšnys. The country now hosts the EMBL Partnership Institute for Genome Editing Technologies at the Vilnius University Life Sciences Center aiming to advance gene editing technologies.

Science 100
article thumbnail

Which pharmaceutical companies have the most drug patents in Ireland?

Drug Patent Watch

This chart shows the pharmaceutical companies with the most patents in Ireland. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is…. The post Which pharmaceutical companies have the most drug patents in Ireland? appeared first on DrugPatentWatch - Make Better Decisions.

article thumbnail

C3G kidney disease: How is it diagnosed and how is it treated?

Antidote

Complement 3 Glomerulopathy, most commonly shortened to C3G or C3G kidney disease, is a rare type of kidney disease that has only been diagnosed since 2013. “C3” refers to a blood protein that has a vital role in the immune system, and “G” is for the damage to glomeruli in the kidneys.

Disease 98
article thumbnail

Deliver Fast, Flexible Clinical Trial Insights with Spotfire

Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.

article thumbnail

Event Recap: Lab of the Future Amsterdam 2022

The Strateos Blog: Drug Discovery

The collaborative spirit in the life sciences sector is at an all-time high. The unprecedented level of cooperation across academia, biopharmaceutical companies, solution providers, startups, and government agencies in the face of one of the biggest public health challenges in recent history, has proven what’s possible when we work towards a common goal.

Science 52
article thumbnail

Five Surprising Facts About GoodRx and the Discount Card Market

Drug Channels

Last month, IQVIA quietly released a fascinating new report on discount cards. (Link below.) The research was sponsored by the Association for Accessible Medicines (AAM). Below, I highlight three unexpected findings from the data regarding GoodRx’s market position, when people use discount cards, how much they save, and why PBMs should still be worried about this market.

article thumbnail

Upcoming Event: Healthcare & Life Sciences Developer Summit November 10, 2022

Nvidia Developer: Drug Discovery

A virtual event designed for healthcare developers and startups, this summit on November 10, 2022 offers a full day of technical talks to reach developers and. A virtual event designed for healthcare developers and startups, this summit on November 10, 2022 offers a full day of technical talks to reach developers and technical leaders in the EMEA region.

Science 52
article thumbnail

Why You Should Consider a Biologics Consulting Service

DS in Pharmatics

Biologics are complex molecular entities that require extensive planning and development strategies to control development costs, ensure compliance with regulations, and speed up a product to commercialization. Hiring a biologics consultant ensures you receive expert advice and support throughout the entire CMC development process. In this article, we will outline why you should consider a biologics consulting service and what benefits this will have for your company.

article thumbnail

Clinical Data Like You´ve Never Seen It Before: Why Spotfire Is the Leading Tool for Clinical Analytics

Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic

article thumbnail

Which pharmaceutical companies have the most drug patents in China?

Drug Patent Watch

This chart shows the pharmaceutical companies with the most patents in China. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is…. The post Which pharmaceutical companies have the most drug patents in China? appeared first on DrugPatentWatch - Make Better Decisions.

article thumbnail

Webinar recap: Lung Cancer Initiative webinar featuring Rich Towne

Antidote

On October 4, Antidote’s Senior Clinical Informatics Manager Dr. Rich Towne participated in a community education webinar for the North Carolina chapter of Lung Cancer Initiative. This webinar was aimed at educating lung cancer patients and professionals in the lung cancer industry on clinical trials and recent advancements in the field.

article thumbnail

Bispecific Antibodies: Successes, Challenges, and Strategies

PerkinElmer

Bispecific antibodies (BsAb) are promising biotherapeutics for an increasing range of diseases. There are currently seven BsAb approved by the U.S. Food and Drug Administration (FDA) and/or the European Medicines Agency (EMA) for a range of indications: Relapsed or refractory precursor B-cell acute lymphoblastic leukemia Bleeding due to hemophilia A Non-small cell lung cancer Unresectable or metastatic uveal melanoma Wet (neovascular) age-related macular degeneration and diabetic macular edema R

article thumbnail

What Pharma Companies Can Expect From the Influx of Humira Biosimilars

Drug Channels

Today’s guest post comes from Steve Callahan, Senior Manager of Market Research at MMIT. Steve walks us through the expected Humira biosimilars launches and discusses potential responses from payers. To learn more, check out MMIT’s Strategic Launch Report & Evaluate Forecast solution. Read on for Steve’s insights. Read more » Copyright © 2006-2022 Pembroke Consulting, Inc. d/b/a Drug Channels Institute.

article thumbnail

Fall 2022 Clinical API Feature Release

DrugBank

Are you ready for another round-up for our latest Clinical features and updates? This season, we have new plugins, Allergies module, even better therapeutic categories and alternatives, and much more to help you bring your offerings to the next level. Let's dive in! Conditions Search Plugin and ICD-10 Search Plugin Read More Below We’ve created ready-to-use plugins that make searching conditions and ICD-10 concepts quick and easy!

Drugs 52
article thumbnail

Modernizing Site Feasibility and Selection

Advarra

Study startup is a complicated, multi-faceted process – notoriously prone to delays due to the many stakeholders, systems, and decisions involved. One decision that can greatly impact the success and efficiency of your study is determining which sites you will partner with to conduct the study. Historically, this process has been littered with pain points and inefficiencies for both sponsors, contract research organizations (CROs), and research sites.

article thumbnail

Which pharmaceutical drugs have the most drug patents in Canada?

Drug Patent Watch

This chart shows the drugs with the most patents in Canada. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.…. The post Which pharmaceutical drugs have the most drug patents in Canada? appeared first on DrugPatentWatch - Make Better Decisions.

article thumbnail

World Mental Health Day: A Q&A with NAMI

Antidote

October 10 is World Mental Health Day , a day aimed at raising awareness of mental health and wellness around the globe. For many mental health conditions , it can take a period of trial and error to find the right treatment plan for patients — but through clinical trials, discovering new and more efficient treatments can be made possible.

article thumbnail

Organoid Biobanks: Living Predictive Models for Cancer Drug Development

Crown Bioscience

The need for more clinically relevant preclinical models has been identified as one of the areas that can help reduce the high attrition rate observed for anticancer drugs. Better models, such as Hubrecht Organoid Technology (HUB) tumor organoids , can drive better decisions in drug discovery by identifying agents that will have the best chances of succeeding in clinical trials.

article thumbnail

Building New Data Connections Helps Brands Lower Adherence

Drug Channels

Today’s guest post comes from Kylie Hall, Director of Product Management at ConnectiveRx. Kylie explains how new ways of harnessing patient data can transform the way pharmaceutical companies interact with patients and providers—and ultimately help improve adherence. Click here to learn about the ConnectiveRx Enterprise Data Platform. Read on for Kylie’s insights.

article thumbnail

Leverage the Clinical API: Therapeutic Alternatives

DrugBank

DrugBank’s Clinical API is a powerful tool that can be used across an array of use cases, including everything from EMR/EHR to hospice and precision medicine. We’ve intentionally built our Clinical API to connect multiple data points across unique modules as a means of delivering specific and empowering insights to the full range of our users.

Doctors 52
article thumbnail

What Is An Investigational Device Exemption Application and Study?

DS in Pharmatics

An Investigational Device Exemption (IDE) is an application submitted to obtain the FDA's approval for use of a novel medical device in a clinical study. This allows for the collection of safety and effectiveness data in order to support full market approval.

article thumbnail

Pharmaceutical companies with the most ‘Pediatric Exclusivity’ drugs

Drug Patent Watch

This chart shows the companies which have received the most pediatric exclusivities in the past five years. Pediatric exclusivity is granted to drug companies for conducting pediatric studies on their…. The post Pharmaceutical companies with the most ‘Pediatric Exclusivity’ drugs appeared first on DrugPatentWatch - Make Better Decisions.

article thumbnail

How to get the most out of Antidote Match™

Antidote

At Antidote, our mission is to connect patients with clinical trials using a data-driven, technological approach — and one of the ways we do that is through our clinical trial search engine, Antidote Match ™.

article thumbnail

Unpacking IRB Innovations for Decentralized Clinical Trials

Advarra

In the blink of an eye, the world has gone digital. So many tasks which used to require going to a place and seeing a live human can now be accomplished from an app on our phones. Even the terms “phone” and “watch” seem antiquated, when you consider that little computer in your pocket or attached to your wrist can continuously measure your blood pressure, check your circadian rhythms, or even record changes in mobility and oxygen saturation levels.